Table 1.
General patient and tumor characteristics (n = 2,862)
Category | Subgroups | N of patients | (%) |
---|---|---|---|
Age at time of diagnosis | <40 years | 188 | 6,6 |
40-49 | 562 | 19,6 | |
50-59 | 778 | 27,2 | |
60-69 | 709 | 24,8 | |
70-79 | 423 | 14,8 | |
≥80 | 202 | 7,1 | |
Year of diagnosis | 2009 | 489 | 17,1 |
2010 | 448 | 15,7 | |
2011 | 468 | 16,4 | |
2012 | 483 | 16,9 | |
2013 | 500 | 17,5 | |
2014 | 474 | 16,6 | |
Stage at diagnosis | Stage 0 | 47 | 1,6 |
Stage I | 1063 | 37,1 | |
Stage II | 1174 | 41,0 | |
Stage III | 357 | 12,5 | |
Stage IV | 158 | 5,5 | |
Stage unknown | 63 | 2,2 | |
Tumor Grade | Grade 1 | 319 | 11,1 |
Grade 2 | 1378 | 48,1 | |
Grade 3 | 1126 | 39,3 | |
Grade unknown | 39 | 1,4 | |
Multiple tumors | No | 2733 | 95,5 |
2+ | 129 | 4,5 | |
Treatmenta | Breast Conserving Surgery | 1374 | 48,0 |
Mastectomy | 1311 | 45,8 | |
Radiotherapy | 2354 | 82,3 | |
Chemotherapy | 1296 | 45,3 | |
Hormonal therapy | 2344 | 81,9 | |
Morphology | Ductal | 2118 | 74,0 |
Lobular | 337 | 11,8 | |
Other | 407 | 14,2 |
aSome patients receive multiple different treatment interventions within each subgroup (surgery or systemic therapy) during their follow-up period